Nugenerex Immuno Oncology Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Nugenerex immuno oncology inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Nugenerex Immuno Oncology Inc Today - Breaking & Trending Today

Insider Moves: Bintai Kinden Corp Bhd, Jiankun International Bhd, PNE PCB Bhd, Scope Industries Bhd, Kenanga Investment Bank Bhd, Sunzen Biotech Bhd

Notable filings
BETWEEN Jan 11 and 15, notable shareholding changes took place at several companies listed on Bursa Malaysia, including
Bintai Kinden Corp Bhd, a mechanical and electrical engineering firm that is venturing into the healthcare sector by distributing a Covid-19 vaccine in Southeast Asia.
In a Jan 11 filing, loss-making Bintai Kinden said Handal Jayabina Sdn Bhd had ceased to be a substantial shareholder after divesting 15 million shares or a 3.93% stake on the open market on Jan 7. It is worth noting that Melaka-based Handal Jayabina had just emerged as a substantial shareholder on Jan 6.
As part settlement of outstanding debts owed by Optimal Property Management Sdn Bhd, a wholly-owned subsidiary of Bintai Kinden, 31.8 million shares representing a direct stake of 8.32% were issued to Handal Jayabina. Following the divestment on Jan 7, it is estimated that it still holds about 4.39% of Bintai Kinden. ....

Negeri Sembilan , Handal Jayabina Sdn Bhd , Yee Wei Meng , Nugenerex Immuno , Bintai Kinden , Sdn Bhd , Cita Realiti Sdn Bhd , Handal Jayabina , Datuk Hong Choon Hau , Chuanplus Industries Sdn Bhd , Kenanga Investment Bank Bhd , Malaysia Pacific Corp Bhd , Ubs Ag , Bintai Kinden Corp Bhd , Scope Industries Bhd , Goodway Integrated Industries Bhd , Generex Biotechnology Corp , Oncology Inc , Over At Jiankun International Bhd , Superlon Holdings Bhd , Holdings Bhd , Tokai Tokyo Financial Holdings Inc , Bursa Malaysia , Melaka Based Handal Jayabina , Optimal Property Management Sdn Bhd , Nugenerex Immuno Oncology Inc ,

Bintai Kinden diversifies into property business, less than six months after vaccine venture

KUALA LUMPUR (Jan 21): Bintai Kinden Corp Bhd, whose share price has more than halved since it hit its record high of RM1.39 in early December, announced that it intends to diversify into property development and management as a strategy to reduce its “reliance solely on the mechanical and electrical (M&E) engineering business”.
On top of that, the company is also proposing a private placement exercise to raise fresh capital of RM58.43 million to fund the new venture.
It is worth noting that this is the second venture out of its core M&E business in less than six months. ....

Kuala Lumpur , Melaka Tengah , East Timor , Republic Of , Sdn Bhd , Holistica Melaka , Nugenerex Immuno , Bintai Kinden , Generex Biotechnology Corp , Nusankota Development Sdn Bhd , Oncology Inc , Bintai Holdingsm Sdn Bhd , Bintai Kinden Corp Bhd , Bintai Healthcare Sdn Bhd , Nugenerex Immuno Oncology Inc , Greenie Medi Cold Chain Box , Bintai Holdings , Holistica Penang , Bandar George Town , Main Market Listing Requirements , Bursa Malaysia Securities Bhd , குவாலா லம்பூர் , கிழக்கு டைமர் , குடியரசு ஆஃப் , ஸ்டன் ப்ட் , ஹோலிஸ்டிகா மேலாக ,

Still some ways to go for Malaysian companies' vaccine distribution biz to take off

KUALA LUMPUR (Jan 12): Promising developments on the vaccine front have stirred investor interest in companies that venture into vaccine distribution, in hopes they will be in for bumper profits.
However, it is not clear at this juncture just how much or when these companies can cash in, given just the evaluation process alone for a vaccine to be approved for distribution and use in Malaysia will take five phases. The first phase alone which is the checking of the vaccine dossiers or research documents typically takes between 90 and 120 days, according to the Ministry of Health (MoH).
When contacted, property developer Yong Tai Bhd chief executive officer Datuk Wira Boo Kuang Loon said the company expects to bring its Chinese partner s vaccine into Malaysia by the third quarter of this year, at the earliest, on obtaining approval from the MoH s National Pharmaceutical Regulatory Agency (NPRA). Any vaccines or medicines to be imported into Malaysia for use here will req ....

Kuala Lumpur , Yong Tai , New Zealand , Choon Lui , Bintai Kinden , Nugenerex Immuno , Yong Tai Bhd , Kinsel Sdn Bhd , Genting Bhd , Solution Group Bhd , Nusankota Development Sdn Bhd , Bintai Kinden Corp Bhd , Generex Biotechnology Corp , Sports Ltd , My Eg Services Bhd , Kanger International Bhd , Bintai Holdingsm Sdn Bhd , Oncology Inc , Shenzhen Kangtai Biological Products Co Ltd , Moh Ethics Committee , Ministry Of Health Mo , Moh National Pharmaceutical Regulatory Agency , Datuk Wira Boo Kuang Loon , National Pharmaceutical Regulatory Agency , Ethics Committee , Nugenerex Immuno Oncology Inc ,

Bintai Kinden's partner files trademark for Covid-19 vaccine

’s partner Generex Biotechnology Corporation has filed for a trademark for its li-Key vaccine and patent for its Ii-Key-SARS-CoV-2 vaccine.
In a statement issued on Thursday, Bintai Kinden said the Ii-Key vaccine was designed to be a complete vaccine for the Covid-19.
“The technology offers the safest and best route for the rapid development of a Covid-19 vaccine, ” it said.
It explained the complete vaccine is designed to regulate the immune system to provide a targeted, neutralising antibody response.
Bintai Kinden managing director Ong Choon Lui said Generex’s Covid-19 vaccine was based on the results of the ex-vivo human studies. It will be formulated for phases one and two clinical trials. ....

Kuala Lumpur , New Zealand , East Timor , Republic Of , Choon Lui , Sdn Bhd , Generex Covid , Nugenerex Immuno , Bintai Kinden , Oncology Inc , Generex Biotechnology Corporation , Bintai Kinden Corporation Bhd , Bintai Kinden Corporation , Ong Choon Lui , Nugenerex Immuno Oncology Inc , Healthcare Sdn Bhd , Corporate News , Covid 19 , Generex Biotechnology , குவாலா லம்பூர் , புதியது ஜீலாந்து , கிழக்கு டைமர் , குடியரசு ஆஃப் , சூன் லு , ஸ்டன் ப்ட் , புற்றுநோயியல் இன்க் ,

Generex files trademark and patent for Covid-19 vaccine

KUALA LUMPUR: Bintai Kinden Corp Bhd’s partner, Generex Biotechnology Corp has filed for a trademark for its li-Key vaccine, to be known as “The Compl. ....

Kuala Lumpur , New Zealand , Choon Lui , Sdn Bhd , Nugenerex Immuno , Bintai Kinden , Generex Biotechnology Corp , Oncology Inc , Drug Administration , Bintai Kinden Corp Bhd , Ong Choon Lui , United State Food , Healthcare Sdn Bhd , Nugenerex Immuno Oncology Inc , குவாலா லம்பூர் , புதியது ஜீலாந்து , சூன் லு , ஸ்டன் ப்ட் , புற்றுநோயியல் இன்க் , ஓங் சூன் லு , ஒன்றுபட்டது நிலை உணவு , சுகாதாரம் ஸ்டன் ப்ட் ,